LRRC8D

LRRC8D is an accessory pore-forming subunit of the volume-regulated anion channel (VRAC), assembling as a heteromer with the obligate subunit LRRC8A in a 4:2 stoichiometry to widen and increase the hydrophobicity of the selectivity filter, thereby conferring preferential permeability to uncharged organic osmolytes (taurine, myo-inositol), platinum-based drugs (cisplatin, carboplatin), and blasticidin S while suppressing cGAMP transport (PMID:26530471, PMID:24782309, PMID:33171122, PMID:28833202). Structural studies show that LRRC8D incorporation disrupts leucine-rich repeat domain packing and opens lateral fenestrations that facilitate lipid evacuation from the pore during channel gating, while its first extracellular loop is essential for channel activity and harbors cysteine residues whose oxidation potently inhibits LRRC8A/D currents (PMID:32415200, PMID:29853476, PMID:33932953). N-terminal acetylation of LRRC8D by the Golgi-localized acetyltransferase NAA60 is required for full platinum drug uptake, and LRRC8D co-associates with NADPH oxidase 1 to negatively regulate NF-κB inflammatory signaling in vascular smooth muscle cells (PMID:41053424, PMID:33932953). In vivo, LRRC8D localizes to basolateral membranes of renal proximal tubule cells where its loss causes proximal tubular injury and Fanconi-like symptoms, and it contributes to glucose-stimulated insulin secretion in pancreatic β-cells (PMID:35777784, PMID:29773801).

1. 2014 High

   The molecular identity of LRRC8D as a plasma-membrane protein that physically interacts with LRRC8A/B/C to form heteromeric complexes required for blasticidin S import was established, providing the first functional characterization of this gene.

   Evidence Genetic screen for blasticidin S resistance, co-immunoprecipitation, and immunofluorescence localization in mammalian cells

   PMID:24782309

   Open questions at the time

   • No electrophysiological characterization of the channel
   • Stoichiometry of heteromeric complexes undefined
   • Endogenous substrate spectrum unknown
2. 2015 High

   LRRC8D was shown to determine VRAC substrate specificity, with its incorporation into LRRC8A-containing heteromers substantially increasing permeability to cisplatin and taurine—establishing the principle that accessory subunit composition dictates organic solute selectivity.

   Evidence LRRC8A and LRRC8D knockout in HEK293 cells with isotopic cisplatin uptake and electrophysiology

   PMID:26530471

   Open questions at the time

   • Structural basis for widened selectivity unknown
   • In vivo relevance of cisplatin permeability not tested
3. 2017 High

   Distinct substrate preferences were mapped to specific LRRC8 subunit combinations: LRRC8A/D channels preferentially release uncharged osmolytes (taurine, myo-inositol) while LRRC8A/C/E channels handle charged osmolytes, and LRRC8A/D heteromers were shown to be uniquely inhibited by oxidation through extracellular cysteines.

   Evidence RNAi knockdown with radiotracer efflux assays in rat astrocytes; electrophysiology of defined heteromers with oxidant application in HEK293 cells

   PMID:28833202 PMID:28841766

   Open questions at the time

   • Specific cysteine residues mediating oxidant sensitivity not identified
   • Physiological significance of oxidant regulation unclear
4. 2018 High

   Domain-level determinants of LRRC8D function were resolved: the first extracellular loop (EL1) of LRRC8D is essential for VRAC activity and can confer functionality to homomeric channels, and LRRC8D-containing VRACs in pancreatic β-cells contribute to glucose-induced depolarization and insulin secretion.

   Evidence Domain-swap chimera mutagenesis with electrophysiology; conditional Lrrc8a knockout in β-cells with insulin secretion and glucose tolerance assays in mice

   PMID:29773801 PMID:29853476

   Open questions at the time

   • LRRC8D-specific knockout in β-cells not performed
   • Neurotransmitter permeability of LRRC8D channels in islets inferred but not directly measured
5. 2020 High

   The first atomic-resolution structure of LRRC8D revealed a wider extracellular pore constriction than LRRC8A explaining organic substrate permeability, and functional studies demonstrated that LRRC8D incorporation suppresses cGAMP transport, establishing opposing roles for different LRRC8 subunits in innate immune signaling.

   Evidence Cryo-EM homo-hexamer structure with electrophysiology; CRISPR screens and cGAMP import assays

   PMID:32415200 PMID:33171122

   Open questions at the time

   • Homo-hexamer structure may not represent native heteromeric assembly
   • Mechanism by which LRRC8D suppresses cGAMP permeability not structurally resolved
6. 2021 Medium

   The oxidant sensitivity of LRRC8D-containing channels was mapped to its extracellular loops (EL1/EL2) via chimeric constructs, and LRRC8D was found to physically associate with NADPH oxidase 1 (Nox1), with its knockdown potentiating NF-κB signaling—linking LRRC8D to inflammatory regulation.

   Evidence Chimeric LRRC8C/D electrophysiology with oxidant application; co-immunoprecipitation, siRNA, and NF-κB reporter assays in vascular smooth muscle cells

   PMID:33932953

   Open questions at the time

   • Nox1 interaction validated by single-direction Co-IP; reciprocal validation would strengthen the claim
   • Mechanism by which LRRC8D dampens NF-κB is indirect
7. 2022 High

   In vivo function of LRRC8D was established: it localizes to basolateral membranes of renal proximal tubules, and constitutive knockout causes proximal tubular injury with increased diuresis and Fanconi-like symptoms, demonstrating a requirement for organic solute reabsorption.

   Evidence Epitope-tagged knock-in and constitutive Lrrc8d knockout mice with immunohistochemistry and urine/serum metabolomics

   PMID:35777784

   Open questions at the time

   • Specific organic solutes transported basolaterally not individually identified
   • Compensatory changes in other LRRC8 subunits not assessed
8. 2025 High

   N-terminal acetylation by the Golgi acetyltransferase NAA60 was identified as a required post-translational modification for LRRC8D/A-mediated platinum drug uptake, and LRRC8D knockdown/stability relationships with LRRC8A were further characterized in primary astrocytes.

   Evidence Mass spectrometry, CRISPR knockout, N-terminal mutagenesis, cisplatin uptake assays, and in vivo tumor models; RNAi in primary astrocytes with Western blot

   PMID:41053424 PMID:41740631

   Open questions at the time

   • Whether NAA60 acetylation affects LRRC8D trafficking versus pore gating is unresolved
   • Structural basis for how N-terminal acetylation modulates channel function is unknown

• Key open questions include the high-resolution structure of native heteromeric LRRC8A:D complexes in multiple gating states, the identity of endogenous organic solutes transported in different tissues, whether LRRC8D has functions independent of LRRC8A, and the physiological significance of LRRC8D-Nox1 co-association.
• No structure of the native heteromeric LRRC8A:D complex in a lipid bilayer at high resolution from peer-reviewed work
• Tissue-specific substrate repertoire not systematically defined
• LRRC8D-independent functions not explored